Racial and social factors linked to bladder cancer outcomes
Official title: Racial and social contextual factors in relation to epigenome and bladder cancer outcome.
Funded at Baylor College of Medicine · NIH-11417547 · Data updated 2026-11-12
This grant builds a partnership between Baylor College of Medicine and Texas Southern University to understand how people’s social and living conditions affect bladder cancer outcomes and treatment results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 21, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $59,413 |
| NIH project number | 5P20CA284971-04 |
| Project ID | NIH-11417547 on NIH RePORTER |
Who could benefit from this research
✓Could help
Bladder cancer patients treated at BCM/TSU-affiliated sites who consent to participate and complete the survey.
✕Less likely to help
Patients not participating or not meeting inclusion criteria may not directly benefit from this study.
What this research studies
The project connects BCM and TSU to explore how race, housing, socioeconomic status, and community factors influence bladder cancer progression and patient experiences. It will collect an interview-based survey about housing, smoking, healthcare access, and work history from bladder cancer patients and analyze how these non-medical factors relate to outcomes. Shared resources and collaboration will help translate social and biological insights into better care for people with bladder cancer, especially in communities with poorer outcomes.
Why it matters
Potential benefit: If successful, the work could inform more equitable cancer care and targeted interventions that address social factors affecting bladder cancer outcomes.
How similar studies have gone: Past research shows social determinants can impact cancer outcomes, supporting the potential for meaningful findings in this area.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Li, Yi — Baylor College of Medicine
- Study coordinator: Li, Yi
Related research
Other NIH-funded projects on the same topics.
-
Population modeling to reduce bladder cancer burden
Aimed at predicting and guiding effective, population-based ways to prevent and control bladder cancer.
-
Blocking a new immune checkpoint in bladder cancer
Researchers are trying medicines that block a newly found immune pathway to help people with bladder cancer, especially those whose tumors do not respond to current immunotherapy.
-
Nrf2 in T cells and how it could boost immune power against bladder cancer
A small grant will explore how a T-cell protein called Nrf2 affects muscle-invasive bladder cancer and whether targeting it could help patients respond better to immune therapies.
-
Understanding why bladder cancer spreads and resists treatment
This grant studies how advanced bladder cancer changes and spreads across the body, aiming to uncover why it’s hard to treat.
-
Molecular clues to bladder cancer cell changes and therapy response
This NIH grant looks at how bladder cancer cells change their identity and how that affects response to treatment, with a focus on aggressive neuroendocrine variants.
-
Repurposing spironolactone to treat bladder cancer inside the bladder
Aims to repurpose spironolactone as an intravesical treatment for non-muscle invasive bladder cancer to help prevent recurrence and progression.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.